Cargando…

Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders

We have recently reported alterations in the plasma concentrations of lysophosphatidic acid (LPA) in patients with substance use disorders. In order to further explore the potential role of the LPA signaling system as biomarker in cocaine use disorders (CUD) we conducted a cross-sectional study with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flores-López, María, García-Marchena, Nuria, Pavón-Morón, Francisco J., Requena-Ocaña, Nerea, Sánchez-Marín, Laura, Martín-Chaves, Laura, García-Medina, Mónica, Pedraza, Carmen, Castilla-Ortega, Estela, Ruiz, Juan J., Rodríguez de Fonseca, Fernando, Araos, Pedro, Serrano, Antonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284796/ https://www.ncbi.nlm.nih.gov/pubmed/37344453 http://dx.doi.org/10.1038/s41398-023-02523-1

Ejemplares similares

Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder
por: Requena-Ocaña, Nerea, et al.
Publicado: (2023)

Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders
por: Flores-López, María, et al.
Publicado: (2022)

Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease
por: Flores-López, María, et al.
Publicado: (2021)

Influence of gender and education on cocaine users in an outpatient cohort in Spain
por: Requena-Ocaña, Nerea, et al.
Publicado: (2021)

Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients
por: García-Marchena, Nuria, et al.
Publicado: (2020)

Higher Impulsivity As a Distinctive Trait of Severe Cocaine Addiction among Individuals Treated for Cocaine or Alcohol Use Disorders
por: García-Marchena, Nuria, et al.
Publicado: (2018)

Plasma Amino Acid Concentrations in Patients with Alcohol and/or Cocaine Use Disorders and Their Association with Psychiatric Comorbidity and Sex
por: García-Marchena, Nuria, et al.
Publicado: (2022)

Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder
por: Requena-Ocaña, Nerea, et al.
Publicado: (2022)

Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder
por: Herrera-Imbroda, Jesús, et al.
Publicado: (2023)

Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients
por: Herrera-Imbroda, Jesús, et al.
Publicado: (2023)

Sex Differences in Psychiatric Comorbidity and Plasma Biomarkers for Cocaine Addiction in Abstinent Cocaine-Addicted Subjects in Outpatient Settings
por: Pedraz, María, et al.
Publicado: (2015)

Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients
por: Araos, Pedro, et al.
Publicado: (2019)

Evaluation of neurotrophic factors and education level as predictors of cognitive decline in alcohol use disorder
por: Requena-Ocaña, Nerea, et al.
Publicado: (2021)

1-Oleoyl Lysophosphatidic Acid: A New Mediator of Emotional Behavior in Rats
por: Castilla-Ortega, Estela, et al.
Publicado: (2014)

Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder
por: Requena-Ocaña, Nerea, et al.
Publicado: (2023)

Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder
por: Galván, Sandra Torres, et al.
Publicado: (2021)

Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders
por: García-Marchena, Nuria, et al.
Publicado: (2019)

Plasma Concentrations of BDNF and IGF-1 in Abstinent Cocaine Users with High Prevalence of Substance Use Disorders: Relationship to Psychiatric Comorbidity
por: Pedraz, María, et al.
Publicado: (2015)

Pharmacological blockade of either cannabinoid CB(1) or CB(2) receptors prevents both cocaine-induced conditioned locomotion and cocaine-induced reduction of cell proliferation in the hippocampus of adult male rat
por: Blanco-Calvo, Eduardo, et al.
Publicado: (2014)

Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders
por: García-Marchena, Nuria, et al.
Publicado: (2017)

Plasma Chemokines in Patients with Alcohol Use Disorders: Association of CCL11 (Eotaxin-1) with Psychiatric Comorbidity
por: García-Marchena, Nuria, et al.
Publicado: (2017)

Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (TGFα) as a potential biomarker of consumption and dual diagnosis
por: Maza-Quiroga, Rosa, et al.
Publicado: (2017)

Variation in chemokines plasma concentrations in primary care depressed patients associated with Internet-based cognitive-behavioral therapy
por: Romero-Sanchiz, Pablo, et al.
Publicado: (2020)

Long-lasting memory deficits in mice withdrawn from cocaine are concomitant with neuroadaptations in hippocampal basal activity, GABAergic interneurons and adult neurogenesis
por: Ladrón de Guevara-Miranda, David, et al.
Publicado: (2017)

Effects of Intermittent Alcohol Exposure on Emotion and Cognition: A Potential Role for the Endogenous Cannabinoid System and Neuroinflammation
por: Sanchez-Marin, Laura, et al.
Publicado: (2017)

Oleoylethanolamide Modulates BDNF-ERK Signaling and Neurogenesis in the Hippocampi of Rats Exposed to Δ(9)-THC and Ethanol Binge Drinking During Adolescence
por: Silva-Peña, Daniel, et al.
Publicado: (2019)

Lysophosphatidic Acid and Glutamatergic Transmission
por: Roza, Carolina, et al.
Publicado: (2019)

Effects of acute versus repeated cocaine exposure on the expression of endocannabinoid signaling-related proteins in the mouse cerebellum
por: Palomino, Ana, et al.
Publicado: (2014)

Cocaine-Induced Behavioral Sensitization Is Associated With Changes in the Expression of Endocannabinoid and Glutamatergic Signaling Systems in the Mouse Prefrontal Cortex
por: Blanco, Eduardo, et al.
Publicado: (2014)

Repeated Restraint Stress and Binge Alcohol during Adolescence Induce Long-Term Effects on Anxiety-like Behavior and the Expression of the Endocannabinoid System in Male Rats
por: Sánchez-Marín, Laura, et al.
Publicado: (2022)

2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021)

Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
por: Yang, Bicheng, et al.
Publicado: (2017)

Lysophosphatidic Acid Analogue rather than Lysophosphatidic Acid Promoted the Bone Formation In Vivo
por: Yu, Zi-Li, et al.
Publicado: (2018)

Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse
por: Orio, Laura, et al.
Publicado: (2019)

Lysophosphatidic Acid Signaling in Cancer
por: Brindley, David N.
Publicado: (2020)

Environmental enrichment alleviates cognitive and psychomotor alterations and increases adult hippocampal neurogenesis in cocaine withdrawn mice
por: Mañas‐Padilla, M. Carmen, et al.
Publicado: (2022)

Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies
por: Geraldo, Luiz Henrique Medeiros, et al.
Publicado: (2021)

Lysophosphatidic acid in carcinogenesis and tumor development
por: Albrecht, Wiebke
Publicado: (2018)

Regulation of Tumor Immunity by Lysophosphatidic Acid
por: Lee, Sue Chin, et al.
Publicado: (2020)

Lysophosphatidic Acid Signaling in Diabetic Nephropathy
por: Lee, Jong Han, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8flcmml7mgplqdat13c1hhjjko